Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive patients
Showing 1 - 25 of >10,000
Non-invasive Respiratory Support on Outcome and Its Risks in
Active, not recruiting
- COVID-19
- Hypoxemic Respiratory Failure
- High flow nasal oxygen (HFNO, more than 15 L/min)
-
Rotterdam, Zuid-Holland, NetherlandsErasmus MC
Sep 4, 2023
Thyroid Dysfunction, Hypothyroidism, Hyperthyroidism Trial in Riyadh (Thyroxine)
Completed
- Thyroid Dysfunction
- +2 more
-
Riyadh, Central, Saudi ArabiaSecurity Forces Hospital
May 18, 2022
Non-invasive Oxygenation Strategies in Patients Admitted for
Completed
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- Use of High Flow Nasal Cannula alone
- +2 more
-
Béthune, Nord-Pas-de-Calais, France
- +3 more
Oct 10, 2022
COVID-19 Trial in Napoli, Roma (Hydrogen peroxide, Placebo)
Withdrawn
- COVID-19
- Hydrogen peroxide
- Placebo
-
Roma, ItalyClinica Nuova ITOR
Nov 20, 2022
Covid19 Trial in Madrid (Probiotic: Lactobacillus salivarius + Vit D + Zinc, Placebo)
Completed
- Covid19
- Probiotic: Lactobacillus salivarius + Vit D + Zinc
- Placebo
-
Madrid, SpainHospital Universitario Infanta Leonor
May 27, 2022
Assess Infection Rate of Severe Acute Respiratory Syndrome -
Completed
- Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2)
-
Chicago, IllinoisGreat Lakes Clinical Trials /ID# 224874
Oct 6, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in
Not yet recruiting
- Systemic Sclerosis
- SARS-CoV 2 Vaccination
- (no location specified)
Jul 24, 2023
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Trial in Paris (Post-hospitalization nutritional monitoring)
Recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- Post-hospitalization nutritional monitoring
-
Paris, IIe-de-France, FranceGeriatric Department, Bichat, Beaujon and Bretonneau hospitals
Jun 21, 2021
Antigen Rapid Diagnostic Tests for Community Identification of
Recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2 Infection
- Rapid Antigen Testing
-
Kiambu, KenyaKiambu County
Jul 12, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Ferrara (SARS-Cov-2 infection)
Recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2
- SARS-Cov-2 infection
-
Ferrara, ItalyAzienda Ospedaliera Universitaria di Ferrara
Nov 1, 2022
EuGeni Rapid Antigen Test for Qualitative Detection of Severe
Terminated
- SARS-CoV-2 Infection
- EuGeni SARS-CoV-2 Antigen Rapid Diagnostic Test
-
Split, Croatia
- +4 more
Jan 3, 2023
Nutritional Indices on the Prognosis of SARS-CoV-2 Infection
Recruiting
- COVID-19
-
Chongqing, Chongqing, ChinaThe Second Affiliated Hospital of Chongqing Medical University
Apr 27, 2023
COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and
Active, not recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- +2 more
- SARS-CoV-2 and/or MIS-C Exposure
-
Loma Linda, California
- +19 more
Sep 22, 2022
SARS-CoV Infection, Coronavirus, Corona Virus Infection Trial in Copenhagen (An Oropharyngeal swab)
Recruiting
- SARS-CoV Infection
- +2 more
- An Oropharyngeal swab
-
Copenhagen, Hillerød, Denmark
- +1 more
Jan 10, 2023
Severe Exacerbation of Severe Acute Respiratory Syndrome
Active, not recruiting
- SARS-CoV-2
-
Tokyo, JapanCMIC Co. Ltd.,
Jun 5, 2023
SARS CoV-2 Post-Acute Sequelae Trial in Birmingham (DPA-714 PET/MRI)
Not yet recruiting
- SARS CoV-2 Post-Acute Sequelae
- DPA-714 PET/MRI
-
Birmingham, AlabamaUAB
Dec 16, 2022
Japan After Severe Acute Respiratory Syndrome Coronavirus 2
Not yet recruiting
- SARS-CoV-2
-
Tokyo, JapanCMIC Co., Ltd
Jun 6, 2023
Coronavirus Infection, Severe Acute Respiratory Syndrome Trial in Wolverhampton (Survey, SARS-CoV-2 antibody test)
Active, not recruiting
- Coronavirus Infection
- Severe Acute Respiratory Syndrome
- Survey
- SARS-CoV-2 antibody test
-
Wolverhampton, United KingdomThe Royal Wolverhampton NHS Trust
Aug 15, 2022
Covid19 Trial in Nedlands (anti-SARS-CoV-2 IgY, Placebo)
Completed
- Covid19
- anti-SARS-CoV-2 IgY
- Placebo
-
Nedlands, Western Australia, AustraliaLinear Clinical Research - Harry Perkins Research Institute
Jun 30, 2022
COVID-19 Infection, COVID-19 Vaccine Adverse Reaction Trial in Seoul (LEM-mR203, Placebo)
Not yet recruiting
- COVID-19 Infection
- COVID-19 Vaccine Adverse Reaction
- LEM-mR203
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital Clinical Trials Center
Sep 12, 2023
COVID-19 Trial in New York (Hydroxychloroquine (HCQ))
Completed
- COVID-19
- Hydroxychloroquine (HCQ)
-
New York, New YorkNYU Langone Health
Dec 12, 2022
How Future Surgery Will Benefit From Severe Acute Respiratory
Completed
- COVID-19
- Health Behavior
- COVID-surg-SPIGC questionnaire
-
Roma, Rome, Italy
- +2 more
Nov 17, 2022
Covid19, Hypertension, Corona Persistent Symptoms Trial in Giza (Inspiratory muscle trainer, diaphragmatic release)
Enrolling by invitation
- Covid19
- +2 more
- Inspiratory muscle trainer
- diaphragmatic release
-
Giza, Dokki, EgyptFaculty of Physical Therapy
Jun 17, 2022
SARS-CoV-2, COVID-19 Trial in Monaco (ELISA POCT vs RT-PCR)
Recruiting
- SARS-CoV-2
- COVID-19
- ELISA POCT vs RT-PCR
-
Monaco, MonacoCentre National de Depistage - Espace Leo Ferre
Oct 19, 2021